about
Mpl traffics to the cell surface through conventional and unconventional routesProtein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cellsMegakaryocyte biology and related disordersEndoreplication: polyploidy with purposeRole of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learnedMegakaryocytes, malignancy and bone marrow vascular nichesPathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromesMice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet functionDid dinosaurs have megakaryocytes? New ideas about platelets and their progenitors.Etiology and clinical relevance of elevated platelet count in ICU patients : A retrospective analysis.Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis.A systems-biology analysis of isogenic megakaryocytic and granulocytic cultures identifies new molecular components of megakaryocytic apoptosis.The biogenesis of platelets from megakaryocyte proplatelets.Haematopoietic stem and progenitor cell-targeted therapies for thrombocytopenia.Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications.Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout.New insights and therapeutics for immune-mediated thrombocytopenia.Characterization of a patient with atypical amegakaryocytic thrombocytopenia.Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia.Effects of sepsis on neonatal thrombopoiesis.An ENU-induced recessive mutation in Mpl leads to thrombocytopenia with overdominanceNew insights into the mechanisms of nonimmune thrombocytopenia in neonates.Treatment of immune thrombocytopenic purpura: focus on eltrombopag.Gene therapy of MPL deficiency: challenging balance between leukemia and pancytopenia.The adhesion molecules of L-selectin and ICAM-1 in thrombocytosis and thrombocytopenia.New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?Induced pluripotent stem cell-derived human platelets: one step closer to the clinicDasatinib enhances megakaryocyte differentiation but inhibits platelet formation.Clinical significance of serum cytokine levels and thrombopoietic markers in childhood idiopathic thrombocytopenic purpura.Semaphorin 7A inhibits platelet production from CD34+ progenitor cells.Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia.Mcl-1 and Bcl-xL regulate Bak/Bax-dependent apoptosis of the megakaryocytic lineage at multistagesInfluence of Intravenous Immunoglobulin Treatment on Thrombopoiesis.Eltrombopag: the discovery of a second generation thrombopoietin-receptor agonist.Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.Congenital amegakaryocytic thrombocytopenia (CAMT) presenting as severe pancytopenia in the first month of life.Changes in megakaryocytes in cases of thrombocytopenia: bone marrow aspiration and biopsy analysis.Thrombopoietin receptor agonists in primary immune thrombocytopenia.
P2860
Q24299221-51FA1E11-0EBB-4CA9-B239-1416DB5C1EFDQ24310063-4CDBCDB9-79C9-4123-BFA8-505CDAACA1F2Q24536140-E31A282C-67C1-4E35-AE34-2C14C96A7106Q24654063-746A5096-7C8D-4EAB-917D-38E82DB57570Q26738514-849C2735-6BD4-4B58-9CAE-B86F1CA83215Q26862087-4C4AAEE3-1C6B-4218-BD0A-CB55C03C6E14Q26863182-DC9291F2-0B3D-42D3-B4BE-C0426A04DAB7Q28592055-B845FAC8-D656-4AFD-9D67-DE24E5EC2BC5Q28768968-DD2D9DF0-AFEA-4B43-AC42-A83956579500Q30313293-2C313C64-B2AE-48F8-A9EE-30F8289E6A16Q30486155-1BE28503-8487-458B-B962-E16DA31B39F0Q30528487-16159C2C-2FDB-4E5F-A83B-F31A77076538Q33303491-801B16E1-ECD2-4417-B04E-86EC9BFB0A53Q33369405-799B8B97-375B-488E-9EC8-06B0C1361F87Q33372720-86876349-C717-4AA6-BDFD-8FABEB87AB41Q33375217-22608B39-61AB-4601-8016-907FAE78CF3EQ33376946-3F56E904-47FA-4195-B16F-958FB1481310Q33377901-AC290C94-1996-4F6C-A419-689739246228Q33378274-355CC93E-07A5-4545-8BC5-C1899012A9C7Q33379321-D38E60A8-99A0-42E5-9930-4E5145EA57E9Q33379984-514D9883-0D7E-40B9-A562-1ABAEA53FCDCQ33382312-CB69A5EC-54AA-4F48-901C-79C8F54CE23CQ33382906-819DBB48-3415-43CE-9131-6362A93BC290Q33385976-702B617F-9EF9-4CDB-818B-8D071B7E7C9DQ33386724-0AE90A75-998A-4101-8E7A-8C53A7AAB8D1Q33387278-82921559-10D2-4BDF-B382-4BED79C530D3Q33387735-03214A0D-36E1-4BC3-AE67-538EE0C3A61AQ33389236-694C9B4C-D7EB-4BB4-97F0-BF8D6555B57FQ33393364-C7200162-B750-4459-8CF5-252491A5D545Q33394424-3A2E343A-B2BA-413E-BDA9-4118675AB8FBQ33398637-4867BB97-6A67-4BB4-8094-5D74B26813BBQ33400401-325C724E-E8A9-4783-91DA-4F2F8675D220Q33400527-A986236B-4F24-4F0A-82E1-0CC12791D1D7Q33402322-1BB656F5-F8CF-4DC0-B4D4-6683128A24A1Q33402625-6834F795-5AD4-4DAE-99D0-1887B241E9E3Q33406379-115687B1-00C0-417B-B29F-DF6430607282Q33407110-E338DDAE-ADB0-4D9C-81C5-7A17F1D216F6Q33407357-90B600FD-2AD1-456B-9231-E4A46F1F950EQ33407418-9067CCBF-0684-4D05-A06D-8D715427F1DFQ33407623-9298BA7E-050A-4B4A-9344-B832FCA5451B
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The molecular mechanisms that control thrombopoiesis
@ast
The molecular mechanisms that control thrombopoiesis
@en
The molecular mechanisms that control thrombopoiesis
@nl
type
label
The molecular mechanisms that control thrombopoiesis
@ast
The molecular mechanisms that control thrombopoiesis
@en
The molecular mechanisms that control thrombopoiesis
@nl
prefLabel
The molecular mechanisms that control thrombopoiesis
@ast
The molecular mechanisms that control thrombopoiesis
@en
The molecular mechanisms that control thrombopoiesis
@nl
P2860
P3181
P356
P1476
The molecular mechanisms that control thrombopoiesis
@en
P2093
Kenneth Kaushansky
P2860
P304
P3181
P356
10.1172/JCI26674
P407
P577
2005-12-01T00:00:00Z